Cardiology | CHOP Research Institute


Published on
Jul 2, 2024
CHOP Cardiac Center celebrates innovation with the Cardiac Center Innovation Awards.
Published on
Oct 6, 2023
The Advanced Cardiac Therapies Frontier Program will find new solutions for treating heart failure in children.
Published on
Jul 19, 2023
After one year, a device to treat pulmonary regurgitation proved to be safe and effective.
Published on
Aug 26, 2022
When he’s not at work, CHOP cardiologist David Goldberg, MD, is an avid baseball fan and loves watching and coaching the game.

The purpose of this research study is to learn more about improving the treatment and outcomes for patients who have a diagnosis of a single ventricle, such as Hypoplastic Left Heart Syndrome (HLHS) or similar heart defects.

The purpose of this research study is to find out if stem cells from umbilical cord blood can strengthen the muscle of the right side of the heart for patients diagnosed with Hypolplastic Left Heart Syndrome who are scheduled to undergo the Stage II Glenn surgical procedure.

The Harmony Valve study is for patients in need of pulmonary valve replacement.

Conducting a group of dynamic research projects for families affected by hypoplastic left heart syndrome, including research involving the use of autologous stem cells (from the patient’s own body) derived from umbilical cord blood collected at birth.

Supporting the development and commercialization of promising medical devices that address unmet clinical needs in children.

Dr. Stachelek's research interests are in the cellular and molecular mechanisms that control vasculature inflammation.

stachelek [at]